Psychemedics & TruTouch Announce US Sales/Marketing Distribution Agreement

ACTON and FRAMINGHAM, Mass., Feb. 28, 2013,/PRNewswire/ — Psychemedics Corporation, (NASDAQ: PMD) and TruTouch Technologies, Inc. today announced that they have signed an agreement to market TruTouch’s rapid optical alcohol detection and biometric test in the US. The workplace sobriety assurance solution utilizes an optical-based, non-invasive near-infrared sensor that quickly and accurately measures alcohol consumption. … Read more

Psychemedics Awarded ISO/IEC 17025 International Accreditation

Worldwide Leader in Hair Testing For Drugs of Abuse Recognized Internationally For Highest Quality Laboratory Standards ACTON, Mass., Nov. 7, 2011 /PRNewswire/ — Psychemedics Corporation, hair testing for drugs of abuse pioneer and leader for 25 years, announced today that its laboratory has received international accreditation (ISO/IEC 17025:2005) for a broad spectrum of laboratory testing … Read more

Psychemedics Corporation Announces Third Quarter Profits

Acton, Massachusetts, November 3, 2011 — Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2011. The Company also announced a quarterly dividend of $0.12 per share payable to shareholders of record as of November 17, 2011 to be paid on December 1, 2011. This will be the Company’s … Read more

Psychemedics Corporation Announces Sales & Marketing Agreement with Bupa in UK

News Release PSYCHEMEDICS CORPORATION ANNOUNCES SALES & MARKETING AGREEMENT WITH BUPA IN UK Acton, Massachusetts, May 19, 2009 – Psychemedics Corporation (NASDAQ: PMD) today announced that it has signed a sales and marketing agreement with leading international health and care organization Bupa, to market the patented Psychemedics hair analysis drug test in the UK. Around … Read more

Psychemedics Corporation Declares a $.50/Share Special Dividend

NEWS RELEASE Contact: Raymond Ruddy Vice President and Controller (978) 206-8220 Raymondr@psychemedics.com PSYCHEMEDICS CORPORATION DECLARES A $.50/SHARE SPECIAL DIVIDEND Acton, Massachusetts, November 17, 2008 — Psychemedics Corporation (NASDAQ: PMD) today announced a special dividend of $.50 per share payable December 24, 2008, to shareholders of record on December 10, 2008. Raymond C. Kubacki, Chairman, and … Read more